M. H. Motevalli, S. Taheri, F. Peiravian, and N. Yousefi, “Cost-Effectiveness of Sorafenib for Metastatic Renal Cell Carcinoma: A Systematic Review”, Int Pharm Acta, vol. 2, no. 1, pp. 2e10:1–6, Dec. 2019.